Vikrant Pharmaceuticals Limited
About Vikrant Pharmaceuticals Limited
Data last updated:
Vikrant Pharmaceuticals Limited is a public limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 February 1984 and has been in existence for over 42 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U99999MH1984PLC032190. Its GSTIN is 27AAACV1686L1ZW (Maharashtra).
The company has an authorised share capital of ₹6 Cr and a paid-up capital of ₹2.24 Cr. It was formerly known as Vikrant Pharmaceuticals Private Limited. It is led by directors including Vastupal Ladhani Pratapchand (Managing Director) and Kamala Ladhani Vastupal (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Govind Nivas 1st Floor 62/64 Dhanji Street, Mumbai, Maharashtra, India – 400003.
As per MCA filings, the company has open charges of ₹5.01 Cr and satisfied charges of ₹26.67 Lakh on record. Court records list 9 cases involving the company, including 9 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressGovind Nivas 1st Floor 62/64 Dhanji Street, Mumbai, Maharashtra, India – 400003
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Vikrant Pharmaceuticals Limited FY 2025 filings available
Financial Statement Summary of Vikrant Pharmaceuticals Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | •••• | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Vikrant Pharmaceuticals Limited
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | •••• | •••• | •••• | •••• | •••• |
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Vikrant Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Vikrant Pharmaceuticals Limited
Vikrant Pharmaceuticals Limited is audited by JAGDISH BANSAL & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| JAGDISH BANSAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Vikrant Pharmaceuticals Limited
Vikrant Pharmaceuticals has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kamala Ladhani Vastupal | Whole-Time Director | 15 Mar 1984 | 42 Years 7 Months | Current |
| Vastupal Ladhani Pratapchand | Managing Director | 17 Feb 1984 | 42 Years 7 Months | Current |
| Shruti Neeraj Ladhani | Director | 27 Dec 2016 | 9 Years 9 Months | Current |
Ownership and Shareholding of Vikrant Pharmaceuticals Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Vikrant Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2014 | Bank of India | ₹5 Cr | Open |
| 20 Feb 1988 | Citibank Na | ₹55,000 | Open |
| 05 Jun 2010 | Syndicate Bank | ₹5 Lakh | Satisfied |
| 15 Sep 1987 | New Bank of India | ₹2 Lakh | Satisfied |
| 21 Aug 1985 | New Bank of India | ₹4 Lakh | Satisfied |
Total charge records: 8 View all charges
Legal Cases of Vikrant Pharmaceuticals Limited
Vikrant Pharmaceuticals Limited has 9 court cases on record: 9 filed against it. All cases are disposed. Status as checked between 29 Sep 2026 and 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 7 | 0 |
| High courts | 2 | 2 | 0 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Thane, Maharashtra | Criminal miscellaneous application | Filed against the company by an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed against the company by Deputy Registrar of Company | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Court case (SUMMONS CASES SS) | Filed against the company by Asstt. Registrar of Companies | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by an individual | Disposed |
| District court, Mumbai CMM Courts, Maharashtra | Civil suit | Filed against the company by an individual | Disposed |
Full case history
All 9 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Vikrant Pharmaceuticals Limited
Employment history and EPFO contributions of people linked to Vikrant Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Vikrant Pharmaceuticals Limited
Vikrant Pharmaceuticals has one previous CIN (Corporate Identification Number): U99999MH1984PTC032190. The current CIN is U99999MH1984PLC032190, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U99999MH1984PLC032190 | Current |
| U99999MH1984PTC032190 | Previous |
Recent Activity on Vikrant Pharmaceuticals Limited
Vikrant Pharmaceuticals Limited has 9 board changes on record since 1984: 3 appointments and 6 cessations. The latest: Shruti Neeraj Ladhani ceased to be Additional Director on 30 Sep 2017.
15 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Vikrant Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Vikrant Pharmaceuticals Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Vikrant Pharmaceuticals Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Vikrant Pharmaceuticals Limited
Vikrant Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACV1686L1ZW | Maharashtra | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Vikrant Pharmaceuticals Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vikrant Pharmaceuticals Limited
Vikrant Pharmaceuticals is an active public limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 February 1984 (42+ years old) and is registered under CIN U99999MH1984PLC032190.
Vikrant Pharmaceuticals has 3 current directors:
- Vastupal Ladhani Pratapchand - Managing Director
- Kamala Ladhani Vastupal - Whole-Time Director
- Shruti Neeraj Ladhani - Director
The GSTIN of Vikrant Pharmaceuticals is 27AAACV1686L1ZW, registered in Maharashtra.
The CIN (Corporate Identification Number) of Vikrant Pharmaceuticals is U99999MH1984PLC032190. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vikrant Pharmaceuticals has 9 court cases on record: 9 filed against it. Most are in the district courts.
Vikrant Pharmaceuticals was incorporated on 16 February 1984, making it 42+ years old. It is registered with the Registrar of Companies, Mumbai.
Shruti Neeraj Ladhani ceased to be Additional Director on 30 Sep 2017. Neeraj Vastupal Ladhani ceased to be Director on 27 Dec 2016. Shruti Neeraj Ladhani was appointed as Director on 27 Dec 2016. Vikrant Pharmaceuticals has 9 board changes on record in total.
The registered office of Vikrant Pharmaceuticals is at Govind Nivas 1st Floor 6264 Dhanji Street, Mumbai, Maharashtra, India – 400003.
Vikrant Pharmaceuticals has an authorised share capital of ₹6 Cr and a paid-up capital of ₹2.24 Cr.
Vikrant Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.